First-half sales fell in key markets like the U.S. and the upscale French furniture-maker revised its forecasts down, citing ...

Roche's Genentech division has formed an R&D partnership with Arsenal Biosciences focusing on developing and refining the biotech's programmable T cell-based therapies platform. Genentech is ...

A senior has worked on farms and punished opponents, but his crowning achievement this summer was starting his own business.

Swiss pharma giant Roche won approval from the Food and Drug Administration on Friday for an injectable version of its blockbuster multiple sclerosis therapy Ocrevus, cutting down the time needed ...

Moog — a supplier to Boeing, Airbus and Lockheed Martin — is Thursday's IBD Stock Of The Day as the aerospace and defense ...

New Hampshire Eversource workers headed south on Sunday with crews and supplies to help restore power in states affected by ...

Shares of Roche Holding AG fell after a poster highlighted side effects in an early-stage study of the Swiss pharmaceutical company’s experimental obesity medicine. The poster, released as part ...

Roche Holding AG said it isn’t concerned about side effects in a small study of a weight-loss shot, after details about the trial sent shares tumbling on Monday. “We’re not alarmed at all ...

FRANKFURT, Sept 11 (Reuters) - Roche (ROG.S), opens new tab said on Wednesday the promising results of an early-stage trial of its experimental weight-loss pill that bolstered its shares in July ...

Contractor ISG held at least £1.84bn in government contracts before its collapse, causing a headache for the prison-building ...

Roche is holding out hopes that its injectable obesity prospect could eventually demonstrate 25% weight loss in late-stage trials, the pharma’s head of metabolism R&D has told Fierce Biotech.